FDA Inspection 1320290 — Penn Fertility Care - Lancaster General Health
The FDA completed an inspection of Penn Fertility Care - Lancaster General Health on May 21, 2026 in Lancaster, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 21, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Lancaster, PA (United States)